Simple foot bath may ease chemo fatigue in children
NCT ID NCT06529484
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a nightly warm foot bath can reduce fatigue in children aged 7-12 with lymphoma who are undergoing chemotherapy. Sixty children took a 20-minute foot bath at 38-40°C for 7 days. The goal was to see if this simple, non-drug approach could improve their energy and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- warm water foot bath
- What this could lead to
- If it works, this could offer a simple, drug-free way to reduce fatigue in children undergoing chemotherapy.
- What could go wrong
- This is a small, completed trial with only 60 participants. The results may not apply to all children or cancer types, and the effect might be small or due to placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
7 to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Parents' consent to participate in the study and provide written informed consent. * No diagnosed chronic illness other than cancer. * Parents are literate in Turkish. * Children aged between 7-12 years. * Diagnosis of Stage 3 or 4 Non-Hodgkin Lymphoma. * Receiving the first course of chemotherapy. * Fatigue level of 3 or higher according to the Visual Fatigue Scale by the Oncology Nursing Society of America. Exclusion Criteria: * Children with cancer who have mental retardation and their parents. * Children with cancer who have undergone surgical operations that hinder activities or result in significant organ loss, and their parents. * Children with compromised skin integrity. * Children with cancer and their parents who do not wish to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-Hodgkin lymphoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul University-Cerrahpasa Hospital
Istanbul, Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Double-Drug attack on Hard-to-Treat lymphomas
- Patient's own t cells engineered to hunt lymphoma in early trial
- Immunotherapy injection tested against Hard-to-Treat childhood lymphoma
- Can virtual forests help people with MS sleep better?
- Vaccine aims to train immune system against blood cancers
- A simple walk after surgery might cut recovery time